StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

Analysts at StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a report released on Tuesday. The firm set a “hold” rating on the stock.

Separately, Benchmark reiterated a “speculative buy” rating and issued a $1.25 target price on shares of Milestone Scientific in a research report on Wednesday, November 20th.

Milestone Scientific Stock Performance

Shares of NYSE MLSS opened at $0.79 on Tuesday. The firm has a market cap of $61.61 million, a PE ratio of -11.30 and a beta of 1.08. Milestone Scientific has a one year low of $0.52 and a one year high of $1.10. The firm has a fifty day moving average of $0.83 and a 200 day moving average of $0.84.

Insider Buying and Selling

In related news, Director Leonard Osser sold 107,984 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total value of $100,425.12. Following the completion of the transaction, the director now directly owns 4,606,882 shares in the company, valued at approximately $4,284,400.26. This represents a 2.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Over the last 90 days, insiders have sold 109,193 shares of company stock worth $101,634. 24.75% of the stock is owned by corporate insiders.

Institutional Trading of Milestone Scientific

Several hedge funds have recently made changes to their positions in the business. Y Intercept Hong Kong Ltd purchased a new position in Milestone Scientific in the 3rd quarter valued at approximately $48,000. World Investment Advisors LLC acquired a new stake in shares of Milestone Scientific in the third quarter valued at $91,000. Finally, Geode Capital Management LLC boosted its holdings in Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after purchasing an additional 31,572 shares during the period. Institutional investors and hedge funds own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.